Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1407-1412

  Masago, Miki ^a   Takaai, Mari ^a   Sakata, Jumpei ^a   Horie, Asuka ^a   Ito, Toshikazu ^a   Ishida, Kazuya ^a   Taguchi, Masato ^a   Hashimoto, Yukiya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

LLC PK1 cell; LS180 cell; Procainamide; Quinidine

Indexed keywords

DIPHENHYDRAMINE; IMIPRAMINE; MEPYRAMINE; PROCAINAMIDE; QUINIDINE; TETRYLAMMONIUM;

ALKALINITY; ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; HYDROPHOBICITY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; KIDNEY CELL; KIDNEY TUBULE ABSORPTION; NONHUMAN; TEMPERATURE DEPENDENCE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CATION TRANSPORT PROTEINS; CELL MEMBRANE; DRUG INTERACTIONS; EPITHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; KIDNEY; LLC-PK1 CELLS; PROCAINAMIDE; QUINIDINE; SWINE; TEMPERATURE; TETRAETHYLAMMONIUM;

EID: 77956118694     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1407     Document Type: Article

References (21)

1. Tahara K., Kagawa Y., Takaai M., Taguchi M., Hashimoto Y., Drug Metab. Pharmacokinet., 23, 340-346 (2008).
2. Ishida K., Takaai M., Hashimoto Y., Biol. Pharm. Bull., 29, 522-526 (2006).
3. Martin D. E., Shen J., Griener J., Raasch R., Patterson J. H., Cascio W., J. Clin. Pharmacol., 36, 85-91 (1996).
4. Atkinson A. J. Jr., Ruo T. I., Piergies A. A., Angiology, 39, 655-667 (1988).
5. Drayer D. E., Ann N.Y. Acad. Sci., 432, 45-56 (1984).
6. Karlsson E., Clin. Pharmacokinet., 3, 97-107 (1978).
7. Takaai M., Suzuki H., Ishida K., Tahara K., Hashimoto Y., Biol. Pharm. Bull., 30, 2167-2172 (2007).
8. Fukumori S., Murata T., Takaai M., Tahara K., Taguchi M., Hashimoto Y., Drug Metab. Pharmacokinet., 23, 373-378 (2008).
9. Takaai M., Morishita H., Ishida K., Taguchi M., Hashimoto Y., Eur. J. Pharmacol., 601, 61-65 (2008).
10. Ishida K., Takaai M., Yotsutani A., Taguchi M., Hashimoto Y., Biol. Pharm. Bull., 32, 741-745 (2009).
11. Fukumori S., Masago M., Ishida K., Kayano Y., Taguchi M., Hashimoto Y., Biopharm. Drug Dispos., 30, 448-456 (2009).
12. Koepsell H., Lips K., Volk C., Pharm. Res., 24, 1227-1251 (2007).
13. Handler J. S., Perkins F. M., Johnson J. P., Am. J. Physiol., 238, F1-F9 (1980).
14. Saito H., Yamamoto M., Inui K., Hori R., Am. J. Physiol., 262, C59-C66 (1992).
15. Urakami Y., Kimura N., Okuda M., Masuda S., Katsura T., Inui K., Drug Metab. Pharmacokinet., 20, 200-205 (2005).
16. Takano M., Kato M., Takayama A., Yasuhara M., Inui K., Hori R., Biochim. Biophys. Acta, 1108, 133-139 (1992).
17. Tomita Y., Otsuki Y., Hashimoto Y., Inui K., Pharm. Res., 14, 1236-1240 (1997).
18. Inui K., Saito H., J. Am. Soc. Nephrol., 3, 829 (1992).
19. Sato T., Masuda S., Yonezawa A., Tanihara Y., Katsura T., Inui K., Biochem. Pharmacol., 76, 894-903 (2008).
20. Brandon E. F., Bosch T. M., Deenen M. J., Levink R., van der Wal E., van Meerveld J. B., Bijl M., Beijnen J. H., Schellens J. H., Meijerman I., Toxicol. Appl. Pharmacol., 211, 1-10 (2006).
21. Katsura T., Mizuuchi H., Hashimoto Y., Inui K. I., Am. J. Physiol. Gastrointest. Liver Physiol., 279, G799-G805 (2000).